PRODUCT DETAIL

Ceftazidime Swyssi 1 g prášok na injekčný/infúzny roztok

Code

8897E

MA number

15/0035/25-S

Product Form:

plo ijf 100x1 g (liek.inj.skl.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

Swyssi AG, Germany

Therapeutic Class:

15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01DD	Third-generation cephalosporins
J01DD02	Ceftazidime

Shelf life:

Container:

glass vial

Route of admin.:

Intramuscular or intravenous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	22.02.2025
Validity:	22.02.2030
Pediatric indication:	Yes
Pediatric posology:	Yes
PIL:	PIL_Ceftazidime Swyssi 1 g prášok na injekčný_infúzny roztok_02.2025.pdf
SPC:	SPC_Ceftazidime Swyssi 1 g prášok na injekčný_infúzny roztok_02.2025.pdf
Safety feature	Yes
Data update:	24.02.2025